{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T23:45:19Z","timestamp":1790898319971,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T00:00:00Z","timestamp":1687564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T00:00:00Z","timestamp":1687564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hainan Province","doi-asserted-by":"publisher","award":["No.821QN0983"],"award-info":[{"award-number":["No.821QN0983"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hainan Province","doi-asserted-by":"publisher","award":["No.821QN0983"],"award-info":[{"award-number":["No.821QN0983"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hainan Province","doi-asserted-by":"publisher","award":["No.821QN0983"],"award-info":[{"award-number":["No.821QN0983"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hainan Province","doi-asserted-by":"publisher","award":["No.821QN0983"],"award-info":[{"award-number":["No.821QN0983"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the healthy department of Hainan province","award":["20A200104"],"award-info":[{"award-number":["20A200104"]}]},{"name":"the healthy department of Hainan province","award":["20A200104"],"award-info":[{"award-number":["20A200104"]}]},{"name":"the healthy department of Hainan province","award":["20A200104"],"award-info":[{"award-number":["20A200104"]}]},{"name":"the healthy department of Hainan province","award":["20A200104"],"award-info":[{"award-number":["20A200104"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-023-01122-0","type":"journal-article","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T11:46:34Z","timestamp":1687607194000},"page":"4021-4031","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Exosome-associated miRNA-99a-5p targeting BMPR2 promotes hepatocyte apoptosis during the process of hepatic fibrosis"],"prefix":"10.1007","volume":"23","author":[{"given":"Feng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengfei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunlan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,24]]},"reference":[{"key":"1122_CR1","doi-asserted-by":"publisher","first-page":"574276","DOI":"10.3389\/fimmu.2020.574276","volume":"11","author":"CE McQuitty","year":"2020","unstructured":"McQuitty CE, Williams R, Chokshi S, Urbani L. Immunomodulatory role of the extracellular matrix within the liver disease microenvironment. Front Immunol. 2020;11:574276. https:\/\/doi.org\/10.3389\/fimmu.2020.574276.","journal-title":"Front Immunol"},{"issue":"6","key":"1122_CR2","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1038\/ajg.2017.93","volume":"112","author":"YE Chon","year":"2017","unstructured":"Chon YE, Park JY, Myoung SM, et al. Improvement of liver fibrosis after long-term antiviral therapy assessed by fibroscan in chronic hepatitis B patients with advanced fibrosis. Am J Gastroenterol. 2017;112(6):882\u201391. https:\/\/doi.org\/10.1038\/ajg.2017.93.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"1122_CR3","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1002\/hep.30369","volume":"69","author":"G Szabo","year":"2019","unstructured":"Szabo G, Kamath PS, Shah VH, Thursz M, Mathurin P, Meeting EAJ. Alcohol-related liver disease: areas of consensus, unmet needs and opportunities for further study. Hepatology. 2019;69(5):2271\u201383. https:\/\/doi.org\/10.1002\/hep.30369.","journal-title":"Hepatology"},{"key":"1122_CR4","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnz009","author":"T Marjot","year":"2020","unstructured":"Marjot T, Moolla A, Cobbold JF, Hodson L, Tomlinson JW. Nonalcoholic fatty liver disease in adults: current concepts in etiology, outcomes, and management. Endocr Rev. 2020. https:\/\/doi.org\/10.1210\/endrev\/bnz009.","journal-title":"Endocr Rev"},{"issue":"121","key":"1122_CR5","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","volume":"1","author":"T Higashi","year":"2017","unstructured":"Higashi T, Friedman SL, Hoshida Y. Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev. 2017;1(121):27\u201342. https:\/\/doi.org\/10.1016\/j.addr.2017.05.007.","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"1122_CR6","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.cld.2008.07.008","volume":"12","author":"RG Wells","year":"2008","unstructured":"Wells RG. Cellular sources of extracellular matrix in hepatic fibrosis. Clin Liver Dis. 2008;12(4):759\u201368. https:\/\/doi.org\/10.1016\/j.cld.2008.07.008.","journal-title":"Clin Liver Dis"},{"key":"1122_CR7","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.semcdb.2015.02.005","volume":"40","author":"DK Kim","year":"2015","unstructured":"Kim DK, Lee J, Simpson RJ, Lotvall J, Gho YS. EVpedia: a community web resource for prokaryotic and eukaryotic extracellular vesicles research. Semin Cell Dev Biol. 2015;40:4\u20137. https:\/\/doi.org\/10.1016\/j.semcdb.2015.02.005.","journal-title":"Semin Cell Dev Biol"},{"key":"1122_CR8","doi-asserted-by":"publisher","first-page":"27066","DOI":"10.3402\/jev.v4.27066","volume":"4","author":"M Yanez-Mo","year":"2015","unstructured":"Yanez-Mo M, Siljander PR, Andreu Z, et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles. 2015;4:27066. https:\/\/doi.org\/10.3402\/jev.v4.27066.","journal-title":"J Extracell Vesicles"},{"issue":"8","key":"1122_CR9","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrgastro.2017.71","volume":"14","author":"G Szabo","year":"2017","unstructured":"Szabo G, Momen-Heravi F. Extracellular vesicles in liver disease and potential as biomarkers and therapeutic targets. Nat Rev Gastroenterol Hepatol. 2017;14(8):455\u201366. https:\/\/doi.org\/10.1038\/nrgastro.2017.71.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1122_CR10","doi-asserted-by":"publisher","DOI":"10.1080\/20013078.2018.1461505","author":"L Chen","year":"2018","unstructured":"Chen L, Chen R, Kemper S, Cong M, You H, Brigstock DR. Therapeutic effects of serum extracellular vesicles in liver fibrosis. J Extracell Vesicles. 2018. https:\/\/doi.org\/10.1080\/20013078.2018.1461505.","journal-title":"J Extracell Vesicles"},{"issue":"6","key":"1122_CR11","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1016\/j.jhep.2020.07.014","volume":"73","author":"S Thietart","year":"2020","unstructured":"Thietart S, Rautou PE. Extracellular vesicles as biomarkers in liver diseases: a clinician\u2019s point of view. J Hepatol. 2020;73(6):1507\u201325. https:\/\/doi.org\/10.1016\/j.jhep.2020.07.014.","journal-title":"J Hepatol"},{"issue":"1","key":"1122_CR12","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1186\/s13287-022-03010-y","volume":"13","author":"S Tian","year":"2022","unstructured":"Tian S, Zhou X, Zhang M, et al. Mesenchymal stem cell-derived exosomes protect against liver fibrosis via delivering miR-148a to target KLF6\/STAT3 pathway in macrophages. Stem Cell Res Ther. 2022;13(1):330. https:\/\/doi.org\/10.1186\/s13287-022-03010-y.","journal-title":"Stem Cell Res Ther"},{"key":"1122_CR13","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.toxlet.2019.09.008","volume":"316","author":"X Dai","year":"2019","unstructured":"Dai X, Chen C, Xue J, et al. Exosomal MALAT1 derived from hepatic cells is involved in the activation of hepatic stellate cells via miRNA-26b in fibrosis induced by arsenite. Toxicol Lett. 2019;316:73\u201384. https:\/\/doi.org\/10.1016\/j.toxlet.2019.09.008.","journal-title":"Toxicol Lett"},{"issue":"7","key":"1122_CR14","doi-asserted-by":"publisher","first-page":"10993","DOI":"10.1038\/ncomms10993","volume":"22","author":"J Hyun","year":"2016","unstructured":"Hyun J, Wang S, Kim J, et al. MicroRNA-378 limits activation of hepatic stellate cells and liver fibrosis by suppressing Gli3 expression. Nat Commun. 2016;22(7):10993. https:\/\/doi.org\/10.1038\/ncomms10993.","journal-title":"Nat Commun"},{"issue":"1","key":"1122_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jhep.2018.08.026","volume":"70","author":"T Zhang","year":"2019","unstructured":"Zhang T, Hu J, Wang X, et al. MicroRNA-378 promotes hepatic inflammation and fibrosis via modulation of the NF-kappaB-TNFalpha pathway. J Hepatol. 2019;70(1):87\u201396. https:\/\/doi.org\/10.1016\/j.jhep.2018.08.026.","journal-title":"J Hepatol"},{"key":"1122_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/cells11101715","author":"M Safran","year":"2022","unstructured":"Safran M, Masoud R, Sultan M, et al. Extracellular vesicular transmission of miR-423\u20135p from HepG2 cells inhibits the differentiation of hepatic stellate cells. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11101715.","journal-title":"Cells"},{"issue":"11","key":"1122_CR17","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.1016\/j.ajpath.2016.07.011","volume":"186","author":"L Chen","year":"2016","unstructured":"Chen L, Chen R, Velazquez VM, Brigstock DR. Fibrogenic signaling is suppressed in hepatic stellate cells through targeting of connective tissue growth factor (CCN2) by cellular or exosomal MicroRNA-199a-5p. Am J Pathol. 2016;186(11):2921\u201333. https:\/\/doi.org\/10.1016\/j.ajpath.2016.07.011.","journal-title":"Am J Pathol"},{"issue":"2","key":"1122_CR18","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.bbrc.2015.09.166","volume":"467","author":"A Geiger","year":"2015","unstructured":"Geiger A, Walker A, Nissen E. Human fibrocyte-derived exosomes accelerate wound healing in genetically diabetic mice. Biochem Biophys Res Commun. 2015;467(2):303\u20139. https:\/\/doi.org\/10.1016\/j.bbrc.2015.09.166.","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"1122_CR19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.freeradbiomed.2012.05.007","volume":"53","author":"JX Jiang","year":"2012","unstructured":"Jiang JX, Chen X, Serizawa N, et al. Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4\/NOX1 inhibitor in vivo. Free Radic Biol Med. 2012;53(2):289\u201396. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2012.05.007.","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"1122_CR20","doi-asserted-by":"publisher","first-page":"e17599","DOI":"10.1371\/journal.pone.0017599","volume":"6","author":"VJ Lavallard","year":"2011","unstructured":"Lavallard VJ, Bonnafous S, Patouraux S, et al. Serum markers of hepatocyte death and apoptosis are non invasive biomarkers of severe fibrosis in patients with alcoholic liver disease. PLoS ONE. 2011;6(3):e17599. https:\/\/doi.org\/10.1371\/journal.pone.0017599.","journal-title":"PLoS ONE"},{"issue":"2","key":"1122_CR21","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1136\/gut.2005.088690","volume":"56","author":"Y Inagaki","year":"2007","unstructured":"Inagaki Y, Okazaki I. Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis. Gut. 2007;56(2):284\u201392. https:\/\/doi.org\/10.1136\/gut.2005.088690.","journal-title":"Gut"},{"issue":"2","key":"1122_CR22","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1053\/j.gastro.2021.04.064","volume":"161","author":"NR Gough","year":"2021","unstructured":"Gough NR, Xiang X, Mishra L. TGF-beta signaling in liver, pancreas, and gastrointestinal diseases and cancer. Gastroenterology. 2021;161(2):434-52 e15. https:\/\/doi.org\/10.1053\/j.gastro.2021.04.064.","journal-title":"Gastroenterology"},{"key":"1122_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cells8111419","author":"B Dewidar","year":"2019","unstructured":"Dewidar B, Meyer C, Dooley S, Meindl-Beinker AN. TGF-beta in hepatic stellate cell activation and liver fibrogenesis-updated 2019. Cells. 2019. https:\/\/doi.org\/10.3390\/cells8111419.","journal-title":"Cells"},{"issue":"22","key":"1122_CR24","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.3748\/wjg.v13.i22.3056","volume":"13","author":"F Verrecchia","year":"2007","unstructured":"Verrecchia F, Mauviel A. Transforming growth factor-beta and fibrosis. World J Gastroenterol. 2007;13(22):3056\u201362. https:\/\/doi.org\/10.3748\/wjg.v13.i22.3056.","journal-title":"World J Gastroenterol"},{"issue":"3","key":"1122_CR25","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/s0168-8278(05)80285-5","volume":"18","author":"A Castilla","year":"1993","unstructured":"Castilla A, Prieto J. Human fibrogenesis and transforming growth factor beta-1. J Hepatol. 1993;18(3):378\u20139. https:\/\/doi.org\/10.1016\/s0168-8278(05)80285-5.","journal-title":"J Hepatol"},{"key":"1122_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22158139","author":"T Tadokoro","year":"2021","unstructured":"Tadokoro T, Morishita A, Masaki T. Diagnosis and therapeutic management of liver fibrosis by MicroRNA. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22158139.","journal-title":"Int J Mol Sci"},{"key":"1122_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232113501","author":"X Qi","year":"2022","unstructured":"Qi X, Lai J. Exosomal microRNAs and progression of nonalcoholic steatohepatitis (NASH). Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms232113501.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1122_CR28","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1172\/JCI67968","volume":"124","author":"S Guo","year":"2014","unstructured":"Guo S, Booten SL, Aghajan M, et al. Antisense oligonucleotide treatment ameliorates alpha-1 antitrypsin-related liver disease in mice. J Clin Invest. 2014;124(1):251\u201361. https:\/\/doi.org\/10.1172\/JCI67968.","journal-title":"J Clin Invest"},{"key":"1122_CR29","doi-asserted-by":"publisher","first-page":"1116518","DOI":"10.3389\/fimmu.2023.1116518","volume":"14","author":"W Lu","year":"2023","unstructured":"Lu W, Tang H, Li S, Bai L, Chen Y. Extracellular vesicles as potential biomarkers and treatment options for liver failure: a systematic review up to March 2022. Front Immunol. 2023;14:1116518. https:\/\/doi.org\/10.3389\/fimmu.2023.1116518.","journal-title":"Front Immunol"},{"issue":"7893","key":"1122_CR30","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/s41586-021-04234-3","volume":"601","author":"R Garcia-Martin","year":"2022","unstructured":"Garcia-Martin R, Wang G, Brandao BB, et al. MicroRNA sequence codes for small extracellular vesicle release and cellular retention. Nature. 2022;601(7893):446\u201351. https:\/\/doi.org\/10.1038\/s41586-021-04234-3.","journal-title":"Nature"},{"issue":"4","key":"1122_CR31","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1136\/gutjnl-2020-322526","volume":"70","author":"X Wang","year":"2021","unstructured":"Wang X, He Y, Mackowiak B, Gao B. MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases. Gut. 2021;70(4):784\u201395. https:\/\/doi.org\/10.1136\/gutjnl-2020-322526.","journal-title":"Gut"},{"issue":"1","key":"1122_CR32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41392-020-0169-z","volume":"5","author":"X Yang","year":"2020","unstructured":"Yang X, Ma L, Wei R, et al. Twist1-induced miR-199a-3p promotes liver fibrosis by suppressing caveolin-2 and activating TGF-beta pathway. Signal Transduct Target Ther. 2020;5(1):75. https:\/\/doi.org\/10.1038\/s41392-020-0169-z.","journal-title":"Signal Transduct Target Ther"},{"key":"1122_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/cells10051097","author":"A Khanam","year":"2021","unstructured":"Khanam A, Saleeb PG, Kottilil S. Pathophysiology and treatment options for hepatic fibrosis: can it be completely cured? Cells. 2021. https:\/\/doi.org\/10.3390\/cells10051097.","journal-title":"Cells"},{"issue":"3","key":"1122_CR34","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1124\/pr.112.005983","volume":"64","author":"E van der Pol","year":"2012","unstructured":"van der Pol E, Boing AN, Harrison P, Sturk A, Nieuwland R. Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol Rev. 2012;64(3):676\u2013705. https:\/\/doi.org\/10.1124\/pr.112.005983.","journal-title":"Pharmacol Rev"},{"issue":"1","key":"1122_CR35","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1186\/s12951-021-01138-2","volume":"19","author":"N Wang","year":"2021","unstructured":"Wang N, Li X, Zhong Z, et al. 3D hESC exosomes enriched with miR-6766-3p ameliorates liver fibrosis by attenuating activated stellate cells through targeting the TGFbetaRII-SMADS pathway. J Nanobiotechnol. 2021;19(1):437. https:\/\/doi.org\/10.1186\/s12951-021-01138-2.","journal-title":"J Nanobiotechnol"},{"key":"1122_CR36","doi-asserted-by":"publisher","first-page":"777462","DOI":"10.3389\/fcell.2021.777462","volume":"9","author":"G Chiabotto","year":"2021","unstructured":"Chiabotto G, Ceccotti E, Tapparo M, Camussi G, Bruno S. Human liver stem cell-derived extracellular vesicles target hepatic stellate cells and attenuate their pro-fibrotic phenotype. Front Cell Dev Biol. 2021;9:777462. https:\/\/doi.org\/10.3389\/fcell.2021.777462.","journal-title":"Front Cell Dev Biol."},{"issue":"7","key":"1122_CR37","doi-asserted-by":"publisher","first-page":"104597","DOI":"10.1016\/j.isci.2022.104597","volume":"25","author":"Z Wan","year":"2022","unstructured":"Wan Z, Yang X, Liu X, et al. M2 macrophage-derived exosomal microRNA-411\u20135p impedes the activation of hepatic stellate cells by targeting CAMSAP1 in NASH model. iScience. 2022;25(7):104597. https:\/\/doi.org\/10.1016\/j.isci.2022.104597.","journal-title":"iScience"},{"issue":"1","key":"1122_CR38","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/hep.31658","volume":"74","author":"X Hou","year":"2021","unstructured":"Hou X, Yin S, Ren R, et al. Myeloid-cell-specific IL-6 signaling promotes MicroRNA-223-enriched exosome production to attenuate NAFLD-associated fibrosis. Hepatology. 2021;74(1):116\u201332. https:\/\/doi.org\/10.1002\/hep.31658.","journal-title":"Hepatology"},{"issue":"6","key":"1122_CR39","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3978\/j.issn.2304-3881.2014.11.06","volume":"3","author":"HT Schon","year":"2014","unstructured":"Schon HT, Weiskirchen R. Immunomodulatory effects of transforming growth factor-beta in the liver. Hepatobiliary Surg Nutr. 2014;3(6):386\u2013406. https:\/\/doi.org\/10.3978\/j.issn.2304-3881.2014.11.06.","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"4","key":"1122_CR40","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1038\/oncsis.2014.11","volume":"3","author":"J Zhang","year":"2014","unstructured":"Zhang J, Jin H, Liu H, et al. MiRNA-99a directly regulates AGO2 through translational repression in hepatocellular carcinoma. Oncogenesis. 2014;3(4):e97. https:\/\/doi.org\/10.1038\/oncsis.2014.11.","journal-title":"Oncogenesis"},{"key":"1122_CR41","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.2147\/IJGM.S354842","volume":"15","author":"AF Gharib","year":"2022","unstructured":"Gharib AF, Eed EM, Khalifa AS, et al. Value of Serum miRNA-96-5p and miRNA-99a-5p as diagnostic biomarkers for hepatocellular carcinoma. Int J Gen Med. 2022;15:2427\u201336. https:\/\/doi.org\/10.2147\/IJGM.S354842.","journal-title":"Int J Gen Med"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01122-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-023-01122-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01122-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T20:21:17Z","timestamp":1698783677000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-023-01122-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,24]]},"references-count":41,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,11]]}},"alternative-id":["1122"],"URL":"https:\/\/doi.org\/10.1007\/s10238-023-01122-0","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,24]]},"assertion":[{"value":"10 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflict of interest to declare that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}